Loading company…
Rainbow develops regenerative medicine products, including a therapy for chronic conditions such as stroke.
Founded in 2019 and based in Sapporo-shi, Japan, Rainbow develops regenerative medicine products, including HUNS001 for chronic conditions such as stroke. In September 2023, it raised JPY 268 million in Series B funding to prepare development of a treatment derived from stroke patients' bone marrow stem cells.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in